CDC Funds Infant Brain Damage Prevention Initiatives

CDC Funds Infant Brain Damage Prevention Initiatives

ArticlePress release
Health & Wellness
Diseases & Conditions
Contributed byKrish Tangella MD, MBAMar 18, 2020

CDC Funds Infant Brain Damage Prevention Initiatives

The Centers for Disease Control and Prevention (CDC) is providing approximately $1.3 million in funding over the next three years for research and the prevention of kernicterus, a serious but preventable type of brain damage in infants that can lead to cerebral palsy, hearing loss and complications with vision and teeth. Recipients are the Pennsylvania Hospital in collaboration with Parents of Infants and Children with Kernicterus (PICK) and Saint Peter’s University Hospital, UMDNJ-Robert Wood Johnson Medical School.

Kernicterus is caused by severe and untreated jaundice. While jaundice is very common in newborn infants, any baby with severe jaundice that is not managed and treated in a timely manner is at risk for kernicterus. However, not every baby with yellow skin will have brain damage because treatment is effective when appropriately administered.

The CDC funding will enable the grantees to develop a kernicterus tracking system and provide resources for a national prevention campaign that will include educational programs to improve the recognition of other risk factors by health care providers and raise awareness among expecting parents. Since kernicterus has not been a reportable condition in the United States, a population-based tracking system will help estimate prevalence, which in turn will lead to increased awareness.

Dr. José F. Cordero, director of the CDC National Center on Birth Defects and Developmental Disabilities (NCBDDD), said early detection is critical to the prevention of the irreversible effects of kernicterus. “Infants discharged less than 48 hours after delivery should be examined by a health care provider within the following two to three days for a routine follow-up and a jaundice assessment,” he said. “It is important that health care providers and expectant parents understand the risks of jaundice if not treated in a timely manner.”

Kernicterus was common in the United States in the 1950's and was the second leading cause of cerebral palsy. It was believed to have been eliminated by the 1970's, although it continued to occur in other parts of the world, principally in underdeveloped countries. However, since the 1990’s, a pilot registry has documented over 125 cases of kernicterus in the United States.

For more information, visit www.cdc.gov/ncbddd/dd/kernicterus.htm

# # #

CDC protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!